You just read:

Protagonist Therapeutics Announces Closing of Janssen License and Collaboration Agreement for PTG-200 and Receipt of $50 Million Payment

News provided by

Protagonist Therapeutics, Inc.

Aug 24, 2017, 16:01 ET